Tag: Anil Raghavan

SPARC achieves enrollment goal in PROSEEK Phase 2 Parkinson’s trial

businessnewstoday- October 30, 2023

Sun Pharma Advanced Research Company Ltd. (SPARC) has announced the successful completion of patient enrollment for the PROSEEK study, a significant global Phase 2 clinical ... Read More

Sun Pharmaceutical gets SEZABY FDA approval for neonatal seizures

businessnewstoday- November 18, 2022

Sun Pharmaceutical Industries has secured approval for SEZABY (phenobarbital sodium powder for injection) from the US Food and Drug Administration (FDA) for the treatment of ... Read More

SPARC signs licensing deal with Visiox for two ophthalmic drug candidates

pallavi123- December 8, 2021

Sun Pharma Advanced Research Company (SPARC) has signed a licensing agreement with Visiox Pharma to award exclusive worldwide rights (except for India and Greater China) ... Read More

Sun Pharma Advanced Research signs licensing deal with Biomodifying

pallavi123- December 4, 2021

Sun Pharma Advanced Research Company (SPARC) has signed an agreement with US-based Biomodifying for the exclusive licensing of the latter’s intellectual property (IP), including all ... Read More

SPARC succeeds in phase 3 trial of PDP-716 in glaucoma patients

pallavi123- May 14, 2021

Sun Pharma Advanced Research Company (SPARC) has succeeded in a phase 3 clinical trial for PDP-716 ophthalmic suspension, its investigational drug for the treatment of ... Read More